Fluorenyl modified N-heterocyclic carbene ligated rare earth metal bis(alkyl) complexes, (Flu-NHC)Ln(CH 2 SiMe 3 ) 2 (Flu-NHC = (C 13 H 8 CH 2 CH 2 (NCHCCHN)C 6 H 2 Me 3 -2,4,6); Ln = Sc ( 1a ); Ln = Y ( 1b ); Ln = Ho ( 1c ); Ln = Lu ( 1d )), were synthesized and fully characterized by NMR and X-ray diffraction analyses. Complexes 1b − d with the activation of Al i Bu 3 and [Ph 3 C][B(C 6 F 5 ) 4 ] exhibited high activity, medium syndio- but remarkably high 3,4-regio-selectivity, and the unprecedented livingness for the polymerization of isoprene. Such distinguished catalytic performances could be maintained under various monomer-to-initiator ratios (500−5000) and broad polymerization temperatures (25−80 °C). The resultant polymers are crystalline, having syndiotactically enriched (racemic enchainment triad rr = 50%, pentad rrrr = 30%) 3,4-regulated (99%) microstructure and high glass-transition temperatures (40−49 °C). In contrast, complex 1a was almost inert, while complexes bearing indenyl modified N-heterocyclic carbene moiety, (Ind-NHC)Ln(CH 2 SiMe 3 ) 2 (Ind-NHC = C 9 H 6 CH 2 CH 2 (NCHCCHN)C 6 H 2 Me 3 -2,4,6; Ln = Sc ( 2a ); Ln = Y ( 2b ); Ln = Ho ( 2c ); Ln = Lu ( 2d )), also showed low activity or selectivity. These differences in catalytic performance could be attributed mainly to the electronics and spacial sterics of the metal center of these precursors.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: